Sign in

Steven Bollipo

@stevenbollipo.bsky.social
1.5K followers 1.1K following 126 posts

Gastroenterologist & Hepatologist from Newcastle, Australia I love cooking, gardening, singing, playing piano, chess, photography and a lot of random things. @stevenbollipo on all social media www.bollipo.com

PostsRepliesMedia
Reposted by Steven Bollipo
Elmhurst Hospital Internal Medicine Residency @elmhurstmedicine.bsky.social · 30/10/2025
Our stellar aspiring gastroenterologists were shining at ACG this weekend! A special shout out to Yujin Jeong, who brought home the presidential award, making the Elmhurst family proud as always! 🥳 #MedSky #GISky #ACG2025 @amcollegegastro.bsky.social
071
Reposted by Steven Bollipo
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Important study on use of ICI post-transplant Only one rejection! #liversky @aasldnews.bsky.social journals.lww.com/lt/abstract/...
021
Reposted by Steven Bollipo
The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 16/10/2025
New research - Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial www.thelancet.com/journals/lan... #GastroSky #MedSky #OncSky
032
Reposted by Steven Bollipo
Atoosa Rabiee @atoosarabiee.bsky.social · 10/09/2025
Save and keep it handy for when you are asked to “clear” patients with cirrhosis. Or as I prefer to say it “have a risk, benefit discussion before surgical procedures” There is also a visual highlight 🤩 journals.lww.com/ajg/fulltext... @amcollegegastro.bsky.social #liversky
052
Reposted by Steven Bollipo
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list #liversky @aasldnews.bsky.social
031
Reposted by Steven Bollipo
Matthias Löhr ʚїɞ @maloehr.bsky.social · 09/10/2025
Well, the latest and presumably last in the famous series #selfiewiththepresident with incoming @myueg.bsky.social president @joostphdrenth.bsky.social on the opportunity of #UEGWeek. He promised to continue the series! Stay tuned!
051
Reposted by Steven Bollipo
Matthias Löhr ʚїɞ @maloehr.bsky.social · 09/10/2025
#UEGWeek 2025 is over&done. A truly global event with 12k participants from 115 countries - mostly from 🇪🇺 but all around the 🌎 with large fraction from 🇺🇸 and 🇯🇵 We are looking forward to another edition next year in Barcelona! Stay tuned @myueg.bsky.social
032
Reposted by Steven Bollipo
Springer Medicine @springermedicine.com · 11/10/2025
Missed #UEGWeek 2025? Find out the key highlights and top stories with our hub page. Access the hub for free here 👉 buff.ly/rGbR5dB #GastroSky #MedNews
011
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 09/10/2025
Scientists and clinicians can play a key role in transforming social media from a threat into a powerful tool for truth💡 Check out highlights from Wendi LeBrett's talk at the Opening Plenary of #UEGWeek, where she shares her perspective on how to fight fake news in medicine.
a screenshot of a video
022
Reposted by Steven Bollipo
Deb Verran @debverran.medsky.social · 09/10/2025
The scientific report of this particular axillary liver transplant procedure utilizing a genetically engineered porcine liver can be found in the EASL associated Journal of Hepatology along with the following succinct editorial #LiverSky www.journal-of-hepatology.eu/article/S016...
journal-of-hepatology.eu
The first human xenogeneic liver transplantation – A landmark event, but what does it mean for hepatology?
The report of the world’s first genetically modified porcine liver transplanted into a human patient, published in Journal of Hepatology, represents a historic clinical milestone (1). It demonstrates ...
041
Reposted by Steven Bollipo
Paul Farkas @gastropaul.bsky.social · 11/10/2025
Canadian GI Guidelines re non ulcer UGI Bleed (endorsed by ASGE) 🤔Bleed from NPL Rec Hemostatic spray over conventional endo therapy 🤔Mallory Weiss with non bleeding visible vessels or clots rec no hemostatic Rx 🤔GAVE: Preferred band ligation over APC, prefer APC to RFA. #GIsky #imsky
061
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 06/10/2025
"Having credible sources online is very powerful." 🧑‍💻 Listen as #UEGWeek Opening Plenary speaker Wendi LeBrett discusses the influence and virality of social media in medicine, highlighting the critical role of trustworthy sources in spreading accurate information.
021
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 06/10/2025
Presented today at #UEGWeek, Phase 2a results reveal that a novel nanoparticle therapy, TPM502, can induce gluten-specific immune tolerance in patients with coeliac disease – a potential first-in-class approach. 📌 Discover more in our bitesize recap.
a white text with green text
122
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 06/10/2025
Couldn’t make it to every session at #UEGWeek? Replay and rewatch UEG Week & PGT 2025 sessions anytime on the congress platform, now including subtitles in 11 languages. 🔗 congressplatform.ueg.eu/recordings
ein Mann und eine Frau zeigen aufeinander
011
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 06/10/2025
Join the @esge-news.bsky.social​ Live Endoscopy tomorrow (Oct. 7)! Top experts will showcase the newest developments in 4K definition diagnostic endoscopy, alongside state-of-the-art therapeutic interventions like EMR, ESD, POEM, and hepatobiliary endoscopy. 🔗 bit.ly/4nbDnXH #UEGWeek
eine Gruppe von Menschen vor einem Bildschirm
011
Steven Bollipo @stevenbollipo.bsky.social · 04/10/2025
Day 1 of #UEGweek loving the sense of humour in Europe!
051
Reposted by Steven Bollipo
United European Gastroenterology @myueg.bsky.social · 26/09/2025
Who's looking forward to UEG Week? 🤩 Beyond world-class science, get ready for star-studded networking opportunities as well with our UEG Community Programme! Find the full details for networking at UEG Week on our website here: bit.ly/3p5cqbK #UEGWeek
a close-up of a brochure
011
Steven Bollipo @stevenbollipo.bsky.social · 27/09/2025
Looking forward to my first #UEGWeek ever! See you all in Berlin soon! Science is great too but what I value most is meeting people in person, catching up with old friends and making new friends! Follow me for all conference updates here and on X, LinkedIn, Facebook and Instagram @myueg.bsky.social
030
Reposted by Steven Bollipo
Anita Afzali MD, MPH, MHCM, FACG, AGAF @ibd-afzali.bsky.social · 26/09/2025
#WCOG25 was about celebrating innovation, achievements, & bonds of our #GlobalGICommunity Gathering of ideas, inspiration, & connections—driving progress & shaping #FutureofGI SAVE THE DATE 30 Sept - 2 Oct #WCOG26 in INDIA!🇮🇳 Join @worldgastroorg.bsky.social & continue advancing our field together
131
Reposted by Steven Bollipo
Paul Farkas @gastropaul.bsky.social · 21/09/2025
2nd Victim Syndrome 🤔Distress we experience after being involved in medical error, adverse event or outcome. Can be severe 🤔Can effect all health workers 🤔Well defined stages 🤔We need wider recognition of SVS, and improved support for ourselves and our colleagues #GIsky #IMsky #Medsky
161
Steven Bollipo @stevenbollipo.bsky.social · 20/09/2025
Beautiful day in Melbourne for Day 1 of #WCOG25 #WCOG_AGW25
020
Reposted by Steven Bollipo
American Society for Gastrointestinal Endoscopy @asgeendo.bsky.social · 14/07/2025
Congratulations to the 2025 Advanced Endoscopy Fellow (AEF) Match Class! This year, 89 fellows matched through ASGE’s AEF Match Program. Check them out! hubs.ly/Q03wX9X50 #GISky #GIFellows #MedSky
031
Reposted by Steven Bollipo
The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 08/07/2025
“The totality of observational studies suggests there is no association between ever versus never use of oral contraceptive and liver cancer risk.” #OncSky #GastroSky #MedSky @oncoalert.bsky.social
022
Steven Bollipo @stevenbollipo.bsky.social · 07/07/2025
@lumirkunovsky.bsky.social welcome to Bluesky 😍
010
Reposted by Steven Bollipo
Atoosa Rabiee @atoosarabiee.bsky.social · 10/06/2025
2 🐥🐥 1 🪨 In this VA study, GLP-1 RA use was a/w a 📉 risk of liver outcomes, death, & harmful alcohol use #Liversky journals.lww.com/ajg/abstract... @amcollegegastro.bsky.social
142
Reposted by Steven Bollipo
Rob Brierley @robbrierley.bsky.social · 06/06/2025
"Legislators must be strong in the face of industry pressure. Alcohol causes one in every four deaths of young adults in Europe. There is no room for compromise: no special exemptions, no self-regulatory loopholes, no concessions. No more sham deadlines or political U-turns." #liversky #medsky
031
Steven Bollipo @stevenbollipo.bsky.social · 03/06/2025
Registered for @myueg.bsky.social UEG Week, see you all in Berlin!
010
Reposted by Steven Bollipo
Rob Brierley @robbrierley.bsky.social · 22/05/2025
Today is the first-ever World Eosinophilic Oesophagitis Day! We’ve just shared some recent #EoE content from the journal, starting with the VOYAGE trial that was published earlier this month 👇 #EoEDay #gastrosky #medsky
051
Reposted by Steven Bollipo
Aleksandra Gruevska @gruevska.bsky.social · 08/05/2025
Excited to present our work at #EASLCongress 2025 (THU-036-YI). See you tomorrow at 1pm on the Track Hub 2 - Basic science to check how we use #massspecimaging and IMC for metabolic profiling of #liver fibrosis. Special thanks to our collaborators and funders @zoehall-icl.bsky.social
094
Steven Bollipo @stevenbollipo.bsky.social · 04/05/2025
Get to know how the scope works! #GastroSky youtube.com/shorts/ezbtp...
youtube.com
Get to know how the scope works! It is an amazing mechanical instrument with intricate work inside.
YouTube video by Steven Bollipo #Scopemanship
031
Reposted by Steven Bollipo
Springer Medicine @springermedicine.com · 21/04/2025
#MedNews - Elective sigmoid resection may be a viable option for recurrent, complicated or persistent painful #diverticulitis, preventing recurrences in the long-term, suggests a 4-year analysis of the LASER trial.  Full story 👉 buff.ly/wBDvi3P #MedSky #GastroSky
buff.ly
Surgery for diverticulitis shows favorable long-term outcomes
Elective sigmoid resection may be a viable option for recurrent, complicated or persistent painful diverticulitis, preventing recurrences in the long-term, suggests a 4-year analysis of the LASER…
011
Reposted by Steven Bollipo
Rainbows In Gastro @rainbowingastro.bsky.social · 18/04/2025
🎉 Huge congratulations to our Executive Director, @spaulliver.bsky.social on receiving the @AGA_Gastro -Pfizer Beacon of Hope Award! 🏆 Your dedication to equity in GI is truly inspiring. We’re proud to have you leading Rainbows in Gastro! 🌈 🔗 gastro.org/news/congrat... #GISky
gastro.org
Congratulations to the recipients of the AGA-Pfizer Beacon of Hope Awards
Congratulations to these incredible providers for their work in fostering a more inclusive and equitable GI community.
021
Steven Bollipo @stevenbollipo.bsky.social · 15/04/2025
My approach to difficult colonoscopy: a short video presentation vimeo.com/1075512254/8...
vimeo.com
Gastroenterology Watch 24 - My Approach to Difficult Colonoscopy (Assoc. Prof. Steven Bollipo MBBS FRACP)
This is "Gastroenterology Watch 24 - My Approach to Difficult Colonoscopy (Assoc. Prof. Steven Bollipo MBBS FRACP)" by Research Review on Vimeo, the home…
130
Reposted by Steven Bollipo
Renu Dhanasekaran @renumathyd.bsky.social · 09/04/2025
We do not routinely biopsy but we are doing it more often than before. I am big proponent for biopsy before systemic therapy as wrote in this review pmc.ncbi.nlm.nih.gov/articles/PMC.... But I still do not think the evidence is strong enough to make it into the guidelines.
pmc.ncbi.nlm.nih.gov
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
The diagnosis and management of hepatocellular carcinoma (HCC) have improved significantly in recent years. With the introduction of immunotherapy-based combination therapy, there has been a notable e...
111
Steven Bollipo @stevenbollipo.bsky.social · 09/04/2025
European HCC guidelines: biopsy before immunotherapy! Is that what you all following? @atoosarabiee.bsky.social @renumathyd.bsky.social @ebtapper.bsky.social #liversky #gastrosky www.annalsofoncology.org/action/showP...
annalsofoncology.org
651
Reposted by Steven Bollipo
Enrique de-Madaria @demadaria.bsky.social · 05/04/2025
Proud to receive the prize for the best oral presentation of the International Biliary Pancreatic Meeting 2025 in Seoul, validation of PAN-PROMISE score for its application in RCTs in acute pancreatitis Thanks to the scientific committee!
0143
Steven Bollipo @stevenbollipo.bsky.social · 04/04/2025
This is one of the 6 top abstracts at the plenary session on Day 1 #ESGEdays2025 The take home message poem is the best! Urgent ‼️ ERCP not always the best idea. Hardik Rughwani from AIG Hyderabad. #Gastrosky #Liversky @esge-news.bsky.social
020
Reposted by Steven Bollipo
Elliot Tapper @ebtapper.bsky.social · 04/04/2025
Let’s talk about sex journals.lww.com/hepcomm/full... #liversky
093
Steven Bollipo @stevenbollipo.bsky.social · 03/04/2025
Day 1 of #ESGEdays2025 the place is buzzing with excitement!
000
Steven Bollipo @stevenbollipo.bsky.social · 02/04/2025
Postgraduate Course #ESGEdays2025 @esge-news.bsky.social
010
Reposted by Steven Bollipo
Hanna Blaney, MD, MPH @blaneymd.medsky.social · 31/03/2025
Encouraging #GISky and #liversky Fellows to apply! 📆 Apply by April 1st!
033
Reposted by Steven Bollipo
Rob Brierley @robbrierley.bsky.social · 30/03/2025
In China, surgeons transplant genetically modified pig liver into patient www.theguardian.com/science/2025... www.nature.com/articles/s41... #LiverSky #MedSky
theguardian.com
Surgeons transplant genetically modified pig liver into Chinese patient
Organ appears to function for 10 days, raising prospect of short-term use for those on transplant list
083
Reposted by Steven Bollipo
Malcolm Tan @ibdgastrodocsg.bsky.social · 29/03/2025
Colorectal cancer screening: - FIT is non-inferior to colonoscopy for CRC-related deaths at 10 years n= 57404 Participation rates higher for FIT (39.9%) vs scope (31.8%) CRC-deaths similar: FIT (0.24%) vs scope (0.22%) #GISky #SurgSky @thelancet.bsky.social www.thelancet.com/journals/lan...
162
Reposted by Steven Bollipo
Rob Brierley @robbrierley.bsky.social · 28/03/2025
Results from COLONPREV out now! 10-year colorectal cancer mortality in FIT group non-inferior to that in colonoscopy group (0·22% vs 0·24%; p for non-inferiority=0·0005) Participation in any form of screening higher in FIT group (39·9% vs 31·8%) @oncoalert.bsky.social #GastroSky #OncSky #MedSky
1127
Reposted by Steven Bollipo
Anand V Kulkarni @anandvkulkarni.bsky.social · 28/03/2025
A survey based study from AIG team and UoH on IT individuals who agreed to undergo tests pubmed.ncbi.nlm.nih.gov/40128210/ >80% have fat in liver 20% have elevated liver enzymes 2% have fibrosis (advanced disease) Fatty liver is curable with exercise (150 min/week) and healthy diet #Liversky
pubmed.ncbi.nlm.nih.gov
Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India - PubMed
The Information Technology (IT) sector is a leading industry that fuels India's economic growth. However, the work culture in this sector often promotes sedentary lifestyle, inadequate physical activi...
111
Steven Bollipo @stevenbollipo.bsky.social · 27/03/2025
Social Media landscape is always evolving. Where are we at in 2025? Come and join me on Spotlight stage at #ESGEdays2025 in Barcelona @esge-news.bsky.social
010
Reposted by Steven Bollipo
European Society of Gastrointestinal Endoscopy @esge-news.bsky.social · 14/03/2025
🔥 Just published ESGE Position Statement: Validation of the GPAT– the Global Polypectomy Assessment Tool🔗 www.esge.com/validation-o... Perform colorectal polypectomy? This paper is a must-read. 👏 Sander Smeets, Maria Eva Argenziano, Alexander C. De Crem, David Tate (pic below) et al
132
Reposted by Steven Bollipo
Hannes Hagström @liverepi.bsky.social · 24/03/2025
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016... Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
journal-of-hepatology.eu
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...
1176
Reposted by Steven Bollipo
European Society of Gastrointestinal Endoscopy @esge-news.bsky.social · 06/02/2025
Celebrating excellence in GI endoscopy! With nearly 2k abstracts submitted to #ESGEDays2025 placing in the top 6 is no small feat. Kudos to these remarkable researchers for their important, impressive work. Watch them in the Presidential Session! esgedays.org
042
Steven Bollipo @stevenbollipo.bsky.social · 14/03/2025
Looking forward to my first trip to Barcelona, 🇪🇸 for @esge-news.bsky.social #ESGEdays2025 Please give me some tips on how to get good at speaking español! I am practicing on @duolingoespanol.bsky.social but I don’t if that is enough.
140